These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 6326684

  • 21. [On the behavior of serum enzymes LDH, GOT and GPT in tumors and the possibility of diagnostic and prognostic conclusions].
    Buchelt L, Hess F.
    Strahlentherapie; 1968 Nov; 136(5):574-80. PubMed ID: 5708883
    [No Abstract] [Full Text] [Related]

  • 22. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
    Shitara N, Nakamura H, Genka S, Takakura K.
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704
    [Abstract] [Full Text] [Related]

  • 23. [Antineoplastic effects and mechanism of action of IFN-alpha on brain tumors with use of fluorescent isothiocyanate-labelled IFN].
    Kawamoto K, Numa Y, Fujiwara H, Matsumura H, Ikegami H, Kurimoto M, Toriyama K.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2346-52. PubMed ID: 3729491
    [Abstract] [Full Text] [Related]

  • 24. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [Abstract] [Full Text] [Related]

  • 25. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y, Bigner DD.
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of recombinant interferon-alpha 2 following intralesional administration in malignant glioma patients.
    Maleci A, Antonelli G, Guidetti B, Dianzani F.
    J Interferon Res; 1987 Feb; 7(1):107-9. PubMed ID: 3585078
    [Abstract] [Full Text] [Related]

  • 27. [Effect of interferon on malignant brain tumor].
    Wakabayashi T, Yoshida J, Kobayashi T, Kageyama N, Kanzaki M.
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1400-6. PubMed ID: 7184455
    [Abstract] [Full Text] [Related]

  • 28. The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme.
    Boëthius J, Blomgren H, Collins VP, Greitz T, Strander H.
    Acta Neurochir (Wien); 1983 Aug; 68(3-4):239-51. PubMed ID: 6308969
    [Abstract] [Full Text] [Related]

  • 29. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE, Miller DW, Barnett GH, Stevens GH, Maffett S, Kim J, Cohen PA, Shu S.
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [Abstract] [Full Text] [Related]

  • 30. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Jun; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 31. [Simplified kit for the measurement of GOT, GPT and LDH using diazonium compounds].
    Matsuzawa T, Nishino H, Katsunuma N, Nishii Y, Ando S.
    Rinsho Byori; 1967 Aug; 15(8):539-43. PubMed ID: 5627509
    [No Abstract] [Full Text] [Related]

  • 32. Effect of human leukocyte interferon on malignant brain tumors.
    Hirakawa K, Ueda S, Nakagawa Y, Suzuki K, Fukuma S, Kita M, Imanishi J, Kishida T.
    Cancer; 1983 Jun 01; 51(11):1976-81. PubMed ID: 6839290
    [Abstract] [Full Text] [Related]

  • 33. Immunological considerations and the malignant glioma problem.
    Mahaley MS.
    Clin Neurosurg; 1968 Jun 01; 15():175-89. PubMed ID: 4333303
    [No Abstract] [Full Text] [Related]

  • 34. Systemic beta-interferon therapy for recurrent gliomas: a brief report.
    Mahaley MS, Dropcho EJ, Bertsch L, Tirey T, Gillespie GY.
    J Neurosurg; 1989 Nov 01; 71(5 Pt 1):639-41. PubMed ID: 2809717
    [Abstract] [Full Text] [Related]

  • 35. Hereditary ability to taste PTC, activity of LDH, LDH5 AF, GOT and GPT in patients with carcinoma of the uterus.
    Jandová A, Milunicová A, Novotná J, Skoda V, Laurová L.
    Neoplasma; 1970 Nov 01; 17(2):169-73. PubMed ID: 5425394
    [No Abstract] [Full Text] [Related]

  • 36. [Advances of BRM therapy of malignant brain tumors].
    Nagai M.
    Gan To Kagaku Ryoho; 1991 Feb 01; 18(2):188-94. PubMed ID: 1992912
    [Abstract] [Full Text] [Related]

  • 37. [Malignant central nervous system tumors are susceptible to specific antibodies].
    Blizniukov OP, Kozmin LD, Oliushin VE, Ostreĭko OV, Filatov MV.
    Vopr Onkol; 2001 Feb 01; 47(1):49-51. PubMed ID: 11317535
    [Abstract] [Full Text] [Related]

  • 38. The pattern of S-LDH isoenzymes and S-GOT after traumatic brain injury.
    Lindblom U, Aberg B.
    Scand J Rehabil Med; 1972 Feb 01; 4(2):61-72. PubMed ID: 4645037
    [No Abstract] [Full Text] [Related]

  • 39. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P, Lapras C.
    Neurochirurgie; 1970 Feb 01; 16(2):143-70. PubMed ID: 4317954
    [No Abstract] [Full Text] [Related]

  • 40. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep 01; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.